Literature DB >> 34363605

HGF can reduce accumulation of inflammation and regulate glucose homeostasis in T2D mice.

Liting Yan1, Xiaoxi He2, Yinghua Tang2, Xiaomin Zhao2, Gang Luo2, Xinhong Wang3.   

Abstract

Hepatocyte growth factor (HGF) has been studied as a protective factor for the survival of islet β cells and regulatory glucose transport and metabolism in many studies. The addition of exogenous HGF to cells or mice is the most common way to study HGF, but the persistence and stability of the administered HGF are unclear. In this experiment, wild-type C57BL6 (WT) mice and HGF-overexpressing transgenic (HGF-Tg) mice were divided into a normal diet (ND) group and an HFD group. The HGF protein level in the liver, kidney, spleen, pancreas, and VAT of HGF-Tg-ND mice was upregulated compared to that of WT-ND mice, and it was also upregulated in HGF-Tg-HFD mice compared to that in WT-HFD mice. In the ND group, though the HGF-Tg-ND mice showed higher fasted blood glucose levels and larger integrated density (IOD) of glucagon-positive cells than WT-ND mice, we found that HGF-Tg-ND mice can still maintain normal glucose tolerance based on an intraperitoneal glucose tolerance test (IPGTT) and an intraperitoneal insulin tolerance test (IPITT). In the HFD group, the HGF-Tg-HFD mice showed insulin sensitivity in IPGTT and IPITT and had larger areas and higher IOD values of islet β cells and smaller areas and IOD values of islet α cells than the WT-HFD mice. HGF-Tg-HFD mice had lower level of serum insulin than WT-HFD mice. The HGF-Tg-HFD mice showed inhibited accumulation of CD4+ T cells, CD8+ T cells, Ly6G+ neutrophils, and F4/80+ macrophages in the blood and tissues and protected liver and kidney functions. Oil Red O-stained liver sections revealed that WT-HFD mice had larger areas and higher IOD values of Oil Red O-positive cells than HGF-Tg-HFD mice, and WT-HFD mice had higher score of NASH. PAS-stained kidney sections found WT-HFD has higher mesangial area/glomerular area × 100% than HGF-Tg-HFD mice. Comparative analyses demonstrated that HGF reduces the proportions of inflammatory cells in the blood and tissues, and protects liver and kidney tissues by regulating glucose homeostasis of type 2 diabetic mice.
© 2021. University of Navarra.

Entities:  

Keywords:  Diabetes; HGF; Inflammation

Mesh:

Substances:

Year:  2021        PMID: 34363605     DOI: 10.1007/s13105-021-00828-7

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  41 in total

1.  Strong association between serum hepatocyte growth factor and metabolic syndrome.

Authors:  Akiko Hiratsuka; Hisashi Adachi; Yoshihisa Fujiura; Sho-Ichi Yamagishi; Yuji Hirai; Mika Enomoto; Akira Satoh; Asuka Hino; Kumiko Furuki; Tsutomu Imaizumi
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

2.  Purification and characterization of a newly identified growth factor specific for epithelial cells.

Authors:  J S Rubin; H Osada; P W Finch; W G Taylor; S Rudikoff; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice.

Authors:  K Kosai; K Matsumoto; H Funakoshi; T Nakamura
Journal:  Hepatology       Date:  1999-07       Impact factor: 17.425

Review 4.  Hepatocyte growth factor twenty years on: Much more than a growth factor.

Authors:  Takahiro Nakamura; Katsuya Sakai; Toshikazu Nakamura; Kunio Matsumoto
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

5.  Circulating level of hepatocyte growth factor predicts incidence of type 2 diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Michael P Bancks; Suzette J Bielinski; Paul A Decker; Naomi Q Hanson; Nicholas B Larson; Hugues Sicotte; Christina L Wassel; James S Pankow
Journal:  Metabolism       Date:  2015-10-21       Impact factor: 8.694

Review 6.  Hepatocyte growth factor: A regulator of inflammation and autoimmunity.

Authors:  Nicolas Molnarfi; Mahdia Benkhoucha; Hiroshi Funakoshi; Toshikazu Nakamura; Patrice H Lalive
Journal:  Autoimmun Rev       Date:  2014-12-01       Impact factor: 9.754

7.  Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics.

Authors:  Etheresia Pretorius; Janette Bester; Natasha Vermeulen; Sajee Alummoottil; Prashilla Soma; Antoinette V Buys; Douglas B Kell
Journal:  Cardiovasc Diabetol       Date:  2015-03-08       Impact factor: 9.951

8.  Room-temperature helimagnetism in FeGe thin films.

Authors:  S L Zhang; I Stasinopoulos; T Lancaster; F Xiao; A Bauer; F Rucker; A A Baker; A I Figueroa; Z Salman; F L Pratt; S J Blundell; T Prokscha; A Suter; J Waizner; M Garst; D Grundler; G van der Laan; C Pfleiderer; T Hesjedal
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

Review 9.  The Role of Hepatocyte Growth Factor (HGF) in Insulin Resistance and Diabetes.

Authors:  Alexandre G Oliveira; Tiago G Araújo; Bruno de Melo Carvalho; Guilherme Z Rocha; Andrey Santos; Mario J A Saad
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-30       Impact factor: 5.555

10.  Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation.

Authors:  Shehan N Randeria; Greig J A Thomson; Theo A Nell; Timothy Roberts; Etheresia Pretorius
Journal:  Cardiovasc Diabetol       Date:  2019-06-04       Impact factor: 8.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.